相似文献
1
Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.
Cancer Immunol Immunother. 1993 Nov;37(6):378-84. doi: 10.1007/BF01526794.
2
Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Cell Immunol. 2001 Jun 15;210(2):96-105. doi: 10.1006/cimm.2001.1809.
3
Effects of interferon-gamma and tumour necrosis factor-alpha on the development of cytotoxic T lymphocytes in autologous mixed lymphocyte tumour cultures with human melanoma.
Clin Exp Immunol. 1991 Oct;86(1):163-72. doi: 10.1111/j.1365-2249.1991.tb05790.x.
4
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
Cancer Res. 1991 Apr 15;51(8):2002-8.
5
Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Int J Cancer. 1989 Sep 15;44(3):554-9. doi: 10.1002/ijc.2910440330.
6
Interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) are necessary in the early stages of induction of CD4 and CD8 cytotoxic T cells by Mycobacterium leprae heat shock protein (hsp) 65 kD.
Clin Exp Immunol. 1998 Nov;114(2):196-203. doi: 10.1046/j.1365-2249.1998.00702.x.
7
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
Cancer Immunol Immunother. 1994 Jan;38(1):9-15. doi: 10.1007/BF01517164.
8
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
Cancer Immunol Immunother. 1993 Jul;37(1):15-25. doi: 10.1007/BF01516937.
9
T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
Cancer Immunol Immunother. 1990;32(1):13-21. doi: 10.1007/BF01741719.
10
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
J Exp Med. 1994 Dec 1;180(6):2371-6. doi: 10.1084/jem.180.6.2371.
引用本文的文献
1
Intermittent interferon and polychemotherapy in metastatic melanoma.
J Cancer Res Clin Oncol. 1995;121(3):175-80. doi: 10.1007/BF01198100.
本文引用的文献
1
MHC imbalance and metastatic spread in Lewis lung carcinoma clones.
Int J Cancer. 1983 Jul 15;32(1):113-20. doi: 10.1002/ijc.2910320118.
2
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.
Nature. 1984;308(5955):145-9. doi: 10.1038/308145a0.
3
OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules.
J Immunol. 1984 Oct;133(4):1705-9.
4
Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
J Exp Med. 1984 Jul 1;160(1):255-69. doi: 10.1084/jem.160.1.255.
5
Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene.
Science. 1985 Apr 5;228(4695):26-30. doi: 10.1126/science.3975631.
6
B-cell stimulatory factor-1/interleukin 4.
Annu Rev Immunol. 1987;5:429-59. doi: 10.1146/annurev.iy.05.040187.002241.
7
Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4.
J Immunol. 1988 Mar 1;140(5):1548-54.
8
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
J Exp Med. 1988 Oct 1;168(4):1419-41. doi: 10.1084/jem.168.4.1419.
9
In vitro antigenic modulation of human neuroblastoma cells induced by IFN-gamma, retinoic acid and dibutyryl cyclic AMP.
Int J Cancer. 1987 Apr 15;39(4):521-9. doi: 10.1002/ijc.2910390420.
Zotero 插件